Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biotechnology Progress|April 16, 2025
Improving trans-cinnamic acid production in a model cyanobacteriumDarcy Hunstiger, Hayley Ma, Andrew J Paton, et al.
Canadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|November 19, 2025
Ethical Tensions in Transitioning to Tiered Models of School-Based Occupational TherapySandra VanderKaay, Wenonah Campbell, Leah Dix, et al.
Blood|November 15, 2013
Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutantsAllison Galanis, Hayley Ma, Trivikram Rajkhowa, et al.
Oncotarget|January 13, 2017
FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitorsBao Nguyen, Allen B Williams, David J Young, et al.
Blood|January 11, 2014
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivoHayley Ma, Bao Nguyen, Li Li, et al.
Oncotarget|September 26, 2018
Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3Kozo Nagai, Lihong Hou, Li Li, et al.
Cell Reports. Medicine|May 3, 2025
Characterization and comparative analysis of multifunctional natural killer cell engagers during antitumor responsesHang Lin, Ryan Case, Kathy Y Wei, et al.
Science Translational Medicine|June 12, 2015
Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemiaYiting Lim, Lukasz Gondek, Li Li, et al.
Science Translational Medicine|August 26, 2021
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumorsBrian Belmontes, Deepali V Sawant, Wendy Zhong, et al.
Pageof 1